Category: Factly: Science and Technology

Source- This post is based on the article “Centre sets up secure e-mail for 10,000 users in critical ministries” published in “The Hindu” on 17th December 2023. Why in the News? In response to cyber attacks, the Centre has implemented a secure email system for 10,000 users across critical ministries and departments. How will it… Continue reading Cyberthreats: Centre sets up secure e-mail network for staff of critical departments

Source- This post is based on the article “How do web browsers work? | Explained” published in “The Hindu” on 11th December 2023. Why in the News? Web browsers serve as our digital gateways to the expansive realm of the internet. In this article we delve into the complexity of web browsers, unveiling their working… Continue reading Web browsers working

Source– This post is based on the article “Breakthrough Nutraceutical ‘AKTOCYTE’ by the Department of Atomic Energy Set to Transform Cancer Care” published in “PIB” on 13th December 2023. Why in the News? AKTOCYTE tablets have been granted approval by the Food Safety and Standards Authority of India (FSSAI). What are AKTOCYTE tablets? Specifications Details… Continue reading AKTOCYTE tablets – Revolutionizing Cancer Care + Infographic

Source: The post is based on the article “DRESS Syndrome: Painkiller Meftal can have adverse reactions; govt issues drug safety alert” published in “Business Standard” on 8th December 2023 Why in the News? The Indian Pharmacopoeia Commission (IPC) has warned about risks linked to the painkiller Meftal. They have cautioned about possible harmful reactions with… Continue reading DRESS Syndrome: Painkiller Meftal can have adverse reactions; govt issues drug safety alert

Source: The post is based on the article “Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease” published in “The Hindu” on 9th December 2023 Why in the News? The U.S Food and Drug Administration (FDA) has approved a pair of gene therapies named Lyfgenia and Casgevy for the treatment of sickle… Continue reading Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease